Oneness Biotech Co., Ltd. (LUX:ONEA)
10.60
-0.20 (-1.85%)
At close: Jul 31, 2025
Oneness Biotech Revenue
Oneness Biotech had revenue of 25.22M TWD in the quarter ending March 31, 2025, a decrease of -2.30%. This brings the company's revenue in the last twelve months to 117.33M, up 29.78% year-over-year. In the year 2024, Oneness Biotech had annual revenue of 117.93M with 35.89% growth.
Revenue (ttm)
117.33M TWD
Revenue Growth
+29.78%
P/S Ratio
266.00
Revenue / Employee
2.73M TWD
Employees
43
Market Cap
867.81M EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reinet Investments S.C.A. | 798.00M |
Luxempart | 50.29M |
CPI FIM | 167.35M |
Socfinasia | 186.43M |
Socfinaf | 591.38M |
GP Investments | -8.48M |
Velcan Holdings | 2.95M |